Drug recall D-0536-2021
Product
Rybelsus (semaglutide) Tablets 7 mg Once daily Each tablet contains 7 mg semaglutide 30 tablets 3 blister packs. Each pack contains 10 tablets. Rx only NDC 0169-4307-13 Manufactured by: Novo Nordisk A/S DK-2880 Bagsvaerd, Denmark
Reason for recall
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Lots and codes
K082347
Recall details
- Recalling firm
- Cardinal Health Inc., Dublin, OH
- Quantity
- 1189 cartons
- Distribution
- FL, GA, SC
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 15, 2021
- Terminated
- June 17, 2024
Related products
- Ozempic – drug information
- NDC 0169-1709 Ozempic · Semaglutide 9 mg/1 · Novo Nordisk Pharmaceutical Industries, LP
- NDC 0169-4307 Rybelsus · Semaglutide 7 mg/1 · Novo Nordisk Pharmaceutical Industries, LP
- NDC 0169-1715 Ozempic · Semaglutide 1.5 mg/1 · Novo Nordisk Pharmaceutical Industries, LP
- NDC 0169-4314 Rybelsus · Semaglutide 14 mg/1 · Novo Nordisk Pharmaceutical Industries, LP
- NDC 0169-1704 Ozempic · Semaglutide 4 mg/1 · Novo Nordisk Pharmaceutical Industries, LP
- NDC 0169-4303 Rybelsus · Semaglutide 3 mg/1 · Novo Nordisk Pharmaceutical Industries, LP